- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02278497
Assessment of Coronary Flow Reserve by PET-H215O and FFR. Comparison With Dynamic Acquisition Using CZT Camera (WATERDAY)
July 30, 2015 updated by: University Hospital, Caen
Assessment of Coronary Flow Reserve by PET-H215O and FFR in Patients Suspected of Coroanry Artery Disease. a Comparative Study With Dynamic Acquisition Using CZT Camera and 99mcTc-mibi.
The study will assess coronary flow reserve by PET-H215O and FFR in patients suspected of coroanry artery disease.
This a comparative study with dynamic acquisition using CZT camera and 99mcTc-mibi.
20 patients will have those measurements.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Caen, France, 14000
- Recruiting
- Médecine Nucléaire
-
Contact:
- Denis Agostini, MD,PhD
- Phone Number: 0231063246
-
Sub-Investigator:
- Alain MANRIQUE, Md,PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient between 18 and 80 years
- Suspected coronary disease and / or coronary syndrome patient ST-
- Patient who has been informed of the study and has given his informed consent
- Patient affiliated to a social security system.
Exclusion Criteria:
- Patient having no coronary disease at coronary angiography with FFR on the 3 main epicardial arteries (absence of ≥ 50% stenosis of at least one artery)
- Delay of Care grater than 30 days between the PET and SPECT imaging and the diagnostic coronary angiography
- Patient with a recent history of myocardial infarction and STEMI, unstable angina
- Patient with extra-cardiac disease whose prognosis can interfere with the treatment decision
- Pregnant or lactating women
- Patient allergic to contrast products during coronary angiography
- Patient with MDRD clearance les than 60 ml / min
- Patient Under guardianship, or unable to understand the purpose of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assess myocardial coronary reserve by cardiac CZT camera and Tcmibi comparing with the PET and the water marked during coronary FFR (Flow Fraction Reserve)
Time Frame: baseline
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
October 28, 2014
First Submitted That Met QC Criteria
October 29, 2014
First Posted (Estimate)
October 30, 2014
Study Record Updates
Last Update Posted (Estimate)
July 31, 2015
Last Update Submitted That Met QC Criteria
July 30, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
Clinical Trials on ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
-
Azienda Ospedaliera Universitaria Integrata VeronaActive, not recruitingCoronary Artery Disease | Coronary Heart Disease (CHD) | Ischemic Heart Disease (IHD)Italy
-
National Institute of Cardiology, Laranjeiras,...CompletedMyocardial IschemiaBrazil
-
Italo PortoAstraZenecaCompletedMyocardial IschemiaItaly
-
Portuguese Society of CardiologyAbbott Medical DevicesUnknownCoronary Artery Disease | Valvular Heart DiseasePortugal
-
Ottawa Heart Institute Research CorporationActive, not recruitingHeart DiseaseCanada, Belgium
-
Seoul National University HospitalSamsung Medical Center; Ulsan University Hospital; Inje University; Keimyung University... and other collaboratorsCompletedStable Angina | ST-segment Elevation Myocardial Infarction | Unstable Angina | Non-ST Elevation Myocardial InfarctionKorea, Republic of, Japan, Spain
-
Samsung Medical CenterChonnam National University Hospital; Chosun University Hospital; Gangneung Asan...CompletedIschemic Heart Disease | Heart Failure With Preserved Ejection Fraction | Microvascular Coronary Artery Disease | Diastolic DysfunctionKorea, Republic of, United States
-
Hospices Civils de LyonCompletedStable Angina | Multivessel Coronary Artery Disease | Vessel Disease | Unstable Angina or Stabilized Non-ST Elevated Myocardial Infarction | Patients With ST-elevated Myocardial Infarction | Revascularization of Culprit Coronary ArteryFrance
-
University Hospital Birmingham NHS Foundation TrustUnknownKidney Disease, Chronic | Myocardial DysfunctionUnited Kingdom
-
ECRI bvBoston Scientific Corporation; Volcano CorporationCompletedHeart Diseases | Cardiovascular Diseases | 3 Vessel Coronary Artery DiseaseNetherlands, Poland, Spain, United Kingdom